Search News:
By Year :
Latest
|
All
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
16 July 2021
Clarification of COVID-19 vaccine import, mRNA technology
01 July 2021
Entry into the related party transaction (Revised)
30 June 2021
Entry into the related party transaction
30 June 2021
Notification on the resale period of the repurchased shares under the share repurchase project for financial project proposes
12 May 2021
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2021
12 May 2021
Financial Performance Quarter 1 (F45) (Reviewed)
12 May 2021
Financial Statement Quarter 1/2021 (Reviewed)
06 May 2021
Disclosure of the Minutes of the 2021 Annual General Meeting of Shareholders on the Company's Website
28 April 2021
Form for Report on Names of Members and Scope of Work of the Audit Committee (F24-1)
23 April 2021
Shareholders meeting's resolution for the year 2021
20 April 2021
A change of limit for the number of attendances of the 2021 Annual General Meeting of Shareholders
16 April 2021
The establishment of a new subsidiary
22 March 2021
Disclosure of Invitation to the 2021 Annual General Meeting of Shareholders with supporting documents and the 2020 Annual Report on the company's website
25 February 2021
Schedule of the Annual General Meeting of Shareholders for the Year 2021 and Dividend Payment for the Year 2020 (Revised record date)
23 February 2021
Schedule of the Annual General Meeting of Shareholders for the Year 2021 and Dividend Payment for the Year 2020
23 February 2021
Management Discussion and Analysis Yearly Ending 31 Dec 2020
23 February 2021
Financial Performance Yearly (F45) (Audited)
23 February 2021
Financial Statement Yearly 2020 (Audited)
28 January 2021
Appointment of Chief Executive Officer
<<<
<
/ 2
>
>>>